BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 10469123)

  • 21. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
    Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
    Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of H-Ras transformation by the PTEN/MMAC1/TEP1 tumor suppressor gene.
    Tolkacheva T; Chan AM
    Oncogene; 2000 Feb; 19(5):680-9. PubMed ID: 10698513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors.
    Di Vizio D; Cito L; Boccia A; Chieffi P; Insabato L; Pettinato G; Motti ML; Schepis F; D'Amico W; Fabiani F; Tavernise B; Venuta S; Fusco A; Viglietto G
    Oncogene; 2005 Mar; 24(11):1882-94. PubMed ID: 15674339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTEN and Other PtdIns(3,4,5)P
    Csolle MP; Ooms LM; Papa A; Mitchell CA
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells.
    Tanaka M; Koul D; Davies MA; Liebert M; Steck PA; Grossman HB
    Oncogene; 2000 Nov; 19(47):5406-12. PubMed ID: 11103942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5' phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells.
    Taylor V; Wong M; Brandts C; Reilly L; Dean NM; Cowsert LM; Moodie S; Stokoe D
    Mol Cell Biol; 2000 Sep; 20(18):6860-71. PubMed ID: 10958682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological role of phosphatase PTEN in cancer and tissue injury healing.
    Tsugawa K; Jones MK; Sugimachi K; Sarfeh IJ; Tarnawski AS
    Front Biosci; 2002 May; 7():e245-51. PubMed ID: 11991859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The biology and clinical relevance of the PTEN tumor suppressor pathway.
    Sansal I; Sellers WR
    J Clin Oncol; 2004 Jul; 22(14):2954-63. PubMed ID: 15254063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
    Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL
    Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTEN signaling pathways in melanoma.
    Wu H; Goel V; Haluska FG
    Oncogene; 2003 May; 22(20):3113-22. PubMed ID: 12789288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1.
    Bruni P; Boccia A; Baldassarre G; Trapasso F; Santoro M; Chiappetta G; Fusco A; Viglietto G
    Oncogene; 2000 Jun; 19(28):3146-55. PubMed ID: 10918569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model.
    Weng LP; Smith WM; Brown JL; Eng C
    Hum Mol Genet; 2001 Mar; 10(6):605-16. PubMed ID: 11230180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN.
    Tamura M; Gu J; Matsumoto K; Aota S; Parsons R; Yamada KM
    Science; 1998 Jun; 280(5369):1614-7. PubMed ID: 9616126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN.
    Rouault JP; Kuwabara PE; Sinilnikova OM; Duret L; Thierry-Mieg D; Billaud M
    Curr Biol; 1999 Mar; 9(6):329-32. PubMed ID: 10209098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SHIP-2 and PTEN are expressed and active in vascular smooth muscle cell nuclei, but only SHIP-2 is associated with nuclear speckles.
    Déléris P; Bacqueville D; Gayral S; Carrez L; Salles JP; Perret B; Breton-Douillon M
    J Biol Chem; 2003 Oct; 278(40):38884-91. PubMed ID: 12847108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes.
    Cheney IW; Neuteboom ST; Vaillancourt MT; Ramachandra M; Bookstein R
    Cancer Res; 1999 May; 59(10):2318-23. PubMed ID: 10344736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis.
    Wick W; Furnari FB; Naumann U; Cavenee WK; Weller M
    Oncogene; 1999 Jul; 18(27):3936-43. PubMed ID: 10435616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The tumour suppressor PTEN: involvement of a tumour suppressor candidate protein in PTEN turnover.
    Maehama T; Okahara F; Kanaho Y
    Biochem Soc Trans; 2004 Apr; 32(Pt 2):343-7. PubMed ID: 15046605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Genes & cancer. Card no. 28: PTEN (MMAC, TEP-1) (phosphatase and tensin homolog deleted on chromosome 10)].
    Soussi T
    Bull Cancer; 1999 Sep; 86(9):715-6. PubMed ID: 10576807
    [No Abstract]   [Full Text] [Related]  

  • 40. Phosphoinositide phosphatases: just as important as the kinases.
    Dyson JM; Fedele CG; Davies EM; Becanovic J; Mitchell CA
    Subcell Biochem; 2012; 58():215-79. PubMed ID: 22403078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.